Lorediplon
Lorediplon is a nonbenzodiazepine hypnotic drug that is a pyrazolopyrimidine derivative. It was developed by Neurocrine Biosciences and was in clinical trials for the treatment of insomnia but was discontinued.
History[edit | edit source]
Lorediplon was developed by Neurocrine Biosciences, a San Diego-based biopharmaceutical company. The drug was in clinical trials for the treatment of insomnia, but development was discontinued.
Pharmacology[edit | edit source]
Lorediplon is a nonbenzodiazepine hypnotic drug. It is a pyrazolopyrimidine derivative, which is a class of drugs that also includes zaleplon and indiplon. These drugs work by binding to the GABA receptor in the brain, which has a sedative effect.
Clinical trials[edit | edit source]
Lorediplon was in clinical trials for the treatment of insomnia. However, the development of the drug was discontinued for unknown reasons.
See also[edit | edit source]
Lorediplon Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD